// App-Quantinova.ai

1404 : Pemetrexed decreases circulating S100A9-myeloid derived suppressor cells in patients with non-small cell lung cancer

Researchers

Presenter

  • Po-Hao Feng

Principal Investigators

  • Kang-Yun Lee

Medical Centers

  • Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Pemetrexed

  • Docetaxel

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved